Pecaut & Co’s Oracle ORCL Stock Holding History

Pecaut & Co’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,378	Closed	-$2.07M	–	74
2025 Q3	$2.07M	Sell	7,378 -944	-11%	-$240K	0.67%	30
2025 Q2	$1.82M	Sell	8,322 -265	-3%	-$42.8K	0.6%	31
2025 Q1	$1.2M	Sell	8,587 -990	-10%	-$161K	0.41%	34
2024 Q4	$1.6M	Sell	9,577 -1,975	-17%	-$351K	0.55%	31
2024 Q3	$1.97M	Buy	11,552 +10	+0.1%	+$1.45K	0.7%	30
2024 Q2	$1.63M	Hold	11,542	–	–	0.62%	31
2024 Q1	$1.45M	Buy	+11,542	New	+$1.32M	0.54%	33

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pecaut & Co's ORCL Position: Q4 2025 in Review

Pecaut & Co sold out of Oracle (ORCL) in Q4 2025, closing a stake of 7,378 shares — an estimated $2.07M sold.

Pecaut & Co first reported a position in ORCL in Q1 2024 and held it in 7 quarters. The position peaked at $2.07M in Q3 2025. 3,759 funds tracked by Wall St. Rank hold ORCL as of Q4 2025.

Pecaut & Co reported no remaining Oracle position as of Q4 2025 after selling out during the quarter.
Pecaut & Co sold 7,378 Oracle shares in Q4 2025, an estimated $2.07M.
Pecaut & Co first reported a position in Oracle in Q1 2024 and held it in 7 quarters.
Pecaut & Co's Oracle position peaked at $2.07M in Q3 2025.
3,759 funds tracked by Wall St. Rank held Oracle as of Q4 2025.

Based on Pecaut & Co's 13F filing for Q4 2025, filed 10 Feb 2026.